What to Expect From Zimmer Biomet's Next Quarterly Earnings Report

With a market cap of $19.4 billion, Zimmer Biomet Holdings, Inc. (ZBH) operates as a medical technology company worldwide. Founded in 1927, the Warsaw, Indiana-based company designs, manufactures, and markets orthopedic reconstructive products, S.E.T. products, trauma products. The company is expected to report its Q1 earnings on Monday, May 5, before the market opens.

Ahead of the event, analysts expect ZBH to report a profit of $1.77 per share, down 8.8% from a profit of $1.94 per share reported in the year-ago quarter. It has exceeded analysts' earnings estimates in three of the past four quarters, while missing in one quarter. In the previous quarter, it reported EPS of $2.31, which surpassed the consensus estimates marginally.